Mitchell Shawnte — SEC Form 4 filings

SEC reporting owner CIK 1749432. 3 Form 4 filings on record with FilingPulse; latest filed 2026-03-05.

Transaction summary — filings shown

Covers all 3 filings on record, filed 2025-03-03 to 2026-03-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Olema Pharmaceuticals, Inc. (OLMA)CHIEF LEGAL OFFICER33 legs · 40,000 sh · $951,5037

Form 4 filings — Mitchell Shawnte

FiledFormIssuerReported transactionsSource
2026-03-054Olema Pharmaceuticals, Inc. (OLMA)Option exercise (M): 15,000 @ $4.37 · Sale (S): 15,000 @ $23.01 · Option exercise (M): 25,000 @ $4.37 · Sale (S): 24,767 @ $24.25 · Sale (S): 233 @ $24.69 · Option exercise (M): 15,000 (derivative) @ $0 · +1 moreEDGAR
2026-02-044Olema Pharmaceuticals, Inc. (OLMA)Grant/award (A): 220,000 (derivative) @ $0 · Grant/award (A): 56,250 (derivative) @ $0EDGAR
2025-03-034Olema Pharmaceuticals, Inc. (OLMA)Grant/award (A): 450,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1749432 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →